Esophageal Cancer | Tumor

CURE’s esophageal cancer page is a go-to resource for oncology news and updates in the world of esophageal cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in esophageal cancer.

Trial Launched to Investigate Novel Triplet Therapy in Treatment of Rare Gastric or Esophageal Cancer

July 13th 2022, 9:00pm

Article

The manufacturer of one of the cancer treatments announced that it is also participating in clinical trials assessing the safety and efficacy of their product in colorectal and endometrial cancer.

FDA Approves 2 Opdivo-Based Regimens for Esophageal Squamous Cell Carcinoma

May 31st 2022, 1:37pm

Article

Both Opdivo plus Yervoy and Opdivo plus chemotherapy were approved by the Food and Drug Administration to treat patients with esophageal squamous cell carcinoma.

‘Today Show’ Anchor Hoda Kotb Discusses Fertility Issues Following Cancer Diagnosis, Pfizer Pulls Blood Pressure Drugs Due to Cancer Concerns and More

March 25th 2022, 3:00pm

Article

From Pfizer issuing a voluntary recall of three blood pressure drugs due to a high level of a cancer-causing chemical to “Today Show” co-ancho Hoda Kotb discussing her struggles with fertility after receiving a diagnosis of breast cancer, here’s what’s happening in the cancer space this week.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022, 3:02pm

Article

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.

FDA Approves Keytruda With Chemotherapy for Esophageal, Gastroesophageal Cancers

March 22nd 2021, 10:49pm

Article

Keytruda in combination with chemotherapy has just received FDA approval for the treatment of patients with metastatic or locally advanced esophageal and gastroesophageal cancers.

FDA Approves Opdivo to Treat Advanced Esophageal Squamous Cell Carcinoma

June 11th 2020, 4:46am

Article

The Food and Drug Administration approved Opdivo for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma after prior fluoropyrimidine- and platinum-based chemotherapy.

Reducing the Risk for Esophageal Cancer

August 22nd 2019, 1:00am

Article

For patients with Barrett’s esophagus, surveillance, drugs and diet can help prevent the development of cancer.

Thinking Outside the Box With Esophageal Cancer Treatment

August 21st 2019, 11:00pm

Article

As the range of treatments expands, patients with esophageal cancer can advocate for the care that’s best for them.

Keytruda Approved to Treat Advanced Esophageal Cancer: What You Need to Know

August 8th 2019, 12:55am

Article

The Food and Drug Administration’s approval of Keytruda in recurrent locally advanced or metastatic esophageal squamous cell carcinoma led to new progress for this patient population.

FDA Approves Keytruda to Treat Esophageal Squamous Cell Carcinoma

July 31st 2019, 5:51pm

Article

The Food and Drug Administration has approved Keytruda for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus in certain patients.